Astrazeneca Pharma India Ltd buy melinda
Start price
02.11.17
/
50%
?14.22
Target price
07.11.17
€15.60
Performance (%)
12.98%
End price
07.11.17
€16.07
Summary
This prediction ended on 07.11.17 with a price of €16.07. The BUY prediction by melinda finished with a performance of 12.98%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Astrazeneca Pharma India Ltd | - | - | - | - |
| iShares Core DAX® | -0.051% | 4.829% | 17.062% | 18.811% |
| iShares Nasdaq 100 | 1.659% | 2.417% | 38.705% | 56.555% |
| iShares Nikkei 225® | 0.658% | -2.173% | 13.159% | 7.768% |
| iShares S&P 500 | 0.964% | 2.547% | 30.492% | 47.355% |
Comments by melinda for this prediction
In the thread Astrazeneca Pharma India Ltd diskutieren
Pharma SecteurProduits
Calquence (acalabrutinib) Capsules
Firma: Astrazeneca
Genehmigungsdatum: 31. Oktober 2017
Behandlung: Lymphom, Mantelzell
Caléquence (acalabrutinib) ist ein potenter und hoch selektiver Inhibitor des Tyrosinkinase Bruton (BTK) für die Behandlung von Mantelzelllymphom (MCL).
Stopped prediction by melinda for Astrazeneca Pharma India Ltd
Astrazeneca Pharma India Ltd
Start price
Target price
Perf. (%)
?15.49
07.11.17
07.11.17
€16.90
07.05.18
07.05.18
-15.24%
07.05.18
07.05.18
Astrazeneca Pharma India Ltd
Start price
Target price
Perf. (%)
?1,094.0
02.11.17
02.11.17
€1,200.0
07.11.17
07.11.17
12.98%
07.11.17
07.11.17